English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduToo often, the first sign of cardiovascular disease may be a major event like a heart attack, stroke or cardiac arrest. Now, researchers and clinicians at Mayo Clinic are using artificial intelligence (AI) technology to flag heart problems earlier, boosting the abilities of a diagnostic test that has been around for over a century — the electrocardiogram (ECG).
Tag: Hypertrophic Cardiomyopathy
The Medical Minute: Understanding hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy can cause sudden death at any age – but particularly in young people. A Penn State Health heart surgeon discusses prevention.
Cleveland Clinic-Led Trial Shows Drug Effective in Nearly 80% of Patients with Hypertrophic Cardiomyopathy
Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.
New cause of inherited heart condition discovered
A UCL-led research team has identified a new gene as a cause of hypertrophic cardiomyopathy, an inherited heart condition affecting one in 500 people.
A change of heart – New drug for HCM reduces heart mass
For the first time, a medication has impacted heart muscle thickness and function for patients with the most common inherited heart condition, hypertrophic cardiomyopathy, rather than simply addressing their symptoms.
Silencing Expression of Specific Gene Variants May Provide Insight for Treatment of Mutation-associated Cardiomyopathy
Article title: Silencing of MYH7 ameliorates disease phenotypes in human iPSC-cardiomyocytes Authors: Alexandra Dainis, Kathia Zaleta-Rivera, Alexandre Ribeiro, Andrew Chia Hao Chang, Ching Shang, Feng Lan, Paul W. Burridge, W. Robert Liu, Joseph C. Wu, Alex Chia Yu Chang, Beth…
Mayo researchers create, test AI to improve EKG testing for hypertrophic cardiomyopathy
An approach based on artificial intelligence (AI) may allow EKGs to be used to screen for hypertrophic cardiomyopathy in the future. With hypertrophic cardiomyopathy, the heart walls become thick and may interfere with the heart’s ability to function properly. The disease also predisposes some patients to potentially fatal abnormal rhythms. Current EKG technology has limited diagnostic yield for this disease.